Skip to content
915915915

Drawing based on the label description. No photo yet.

“Erlotinib Tablets equivalent to 150 mg of erlotinib are white to off-white, round, film-coated tablets, debossed with '915' on one side and plain on other side”

915 pill

Pill with imprint 915 is white, round, 11 mm and has been identified as Erlotinib 150 mg. It is used for lung cancer. It is supplied by Zydus Pharmaceuticals USA Inc.

Erlotinib 150 mg

Imprint
915
Strength
150 mg
Used for
Lung cancer
Color
White
Shape
Round
Size
11 mm
Score
No score line
Form
Tablet
Manufacturer
Zydus Pharmaceuticals USA Inc
Drug class
Cancer medicine (kinase inhibitor)
NDC
68382-915, 68382-915-06, 68382-915-16, 68382-915-30, 68382-915-84, 70771-1523, 70771-1523-3, 70771-1523-9, 70771-1523-2, 70771-1523-7

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Erlotinib pills and guides

What is Erlotinib used for?

Erlotinib is used for lung cancer.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Non-Small Cell Lung Cancer (NSCLC)

Erlotinib tablets are indicated for:

  • The treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test receiving first-line, maintenance, or second or greater line treatment after progression following at least one prior chemotherapy regimen.

Limitations of use:

  • Safety and efficacy of erlotinib tablets have not been established in patients with NSCLC whose tumors have other EGFR mutations.
  • Erlotinib tablets are not recommended for use in combination with platinum-based chemotherapy.

Pancreatic Cancer

Erlotinib tablet in combination with gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

From the FDA-approved label on DailyMed (published Jun 12, 2024).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 915 and the other side is plain.
  • It is white, round, 11 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Erlotinib Hydrochloride

Inactive: Crospovidone (15 Mpa.s At 5%), Hypromellose 2910 (6 Mpa.s), Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose 101, Microcrystalline Cellulose 102, Polyethylene Glycol 4000, Silicon Dioxide, Sodium Lauryl Sulfate, Talc, Titanium Dioxide

Also distributed by

Zydus Lifesciences Limited

Other pills with imprint 915

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Erlotinib pills